BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37285094)

  • 21. ASO Author Reflections: Is Esophagectomy Necessary after Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma?
    Liu Z; Zhao J; Li Z
    Ann Surg Oncol; 2021 Nov; 28(12):7160-7161. PubMed ID: 34263374
    [No Abstract]   [Full Text] [Related]  

  • 22. ASO Author Reflections: The Impact of Circular FAT1 in Esophageal Squamous Cell Carcinoma: Investigation of a Novel Tumor Suppressor.
    Takaki W; Konishi H; Shoda K; Otsuji E
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):579-580. PubMed ID: 34665360
    [No Abstract]   [Full Text] [Related]  

  • 23. ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma.
    Okamura A; Watanabe M; Okui J; Matsuda S; Takemura R; Kawakubo H; Takeuchi H; Muto M; Kakeji Y; Kitagawa Y; Doki Y
    Ann Surg Oncol; 2023 Apr; 30(4):2186-2187. PubMed ID: 36538253
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical Significance of Intramural Metastasis as an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma.
    Ushimaru Y; Makino T; Tanaka K; Yamashita K; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Nakajima K; Morii E; Eguchi H; Doki Y
    Ann Surg Oncol; 2023 Aug; 30(8):5195-5202. PubMed ID: 37273025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASO Author Reflections: KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma.
    Nakamura S; Kanda M; Kodera Y
    Ann Surg Oncol; 2020 Jul; 27(7):2569-2570. PubMed ID: 32166595
    [No Abstract]   [Full Text] [Related]  

  • 26. ASO Author Reflections: Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma.
    Booka E; Haneda R; Ishii K; Tsubosa Y
    Ann Surg Oncol; 2020 Sep; 27(9):3171-3172. PubMed ID: 32270418
    [No Abstract]   [Full Text] [Related]  

  • 27. ASO Author Reflections: Esophagectomy or Chemoradiotherapy, That is the Question: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma.
    Kanie Y; Okamura A; Asari T; Ishiyama A; Yoshio T; Tsuchida T; Chin K; Watanabe M
    Ann Surg Oncol; 2021 Dec; 28(13):8436-8437. PubMed ID: 34115253
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: Can Circulating Tumor DNA Guide Individualized Treatment for Patients with Esophageal Squamous Cell Carcinoma?
    Morimoto Y; Matsuda S; Kawakubo H; Nakamura K; Kobayashi R; Hisaoka K; Okui J; Takeuchi M; Aimono E; Fukuda K; Nakamura R; Saya H; Nishihara H; Kitagawa Y
    Ann Surg Oncol; 2023 Jun; 30(6):3757-3758. PubMed ID: 36807023
    [No Abstract]   [Full Text] [Related]  

  • 29. ASO Author Reflections: Radiomics-Based Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma.
    Xie C; Hu Y; Han L; Fu J; Vardhanabhuti V; Yang H
    Ann Surg Oncol; 2022 Dec; 29(13):8127-8128. PubMed ID: 35933539
    [No Abstract]   [Full Text] [Related]  

  • 30. ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma.
    Chan WL
    Ann Surg Oncol; 2023 Feb; 30(2):871-872. PubMed ID: 36380255
    [No Abstract]   [Full Text] [Related]  

  • 31. ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
    Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Ann Surg Oncol; 2022 Oct; 29(11):6867-6868. PubMed ID: 35616746
    [No Abstract]   [Full Text] [Related]  

  • 32. ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study.
    Okamura A; Watanabe M; Okui J; Matsuda S; Takemura R; Kawakubo H; Takeuchi H; Muto M; Kakeji Y; Kitagawa Y; Doki Y
    Ann Surg Oncol; 2023 Sep; 30(9):5895-5896. PubMed ID: 37266806
    [No Abstract]   [Full Text] [Related]  

  • 33. Synchronous Resection of Parotid Metastasis With Esophagectomy: A Case Report.
    Suzuki H; Abe T; Sasaki E; Nagao T; Murashima A; Fujieda H; Higaki E; Hanai N
    In Vivo; 2021; 35(4):2337-2340. PubMed ID: 34182515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOX4 overexpression is a poor prognostic factor in patients undergoing curative esophagectomy for esophageal squamous cell carcinoma.
    Chen YH; Lu HI; Lo CM; Hsiao CC; Li SH
    Surgery; 2020 Mar; 167(3):620-627. PubMed ID: 31889545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ASO Author Reflections: Timing of Surgery and Chemoradiation for Esophageal Squamous Cell Carcinoma.
    Wong LY; Berry MF
    Ann Surg Oncol; 2023 Apr; 30(4):2224-2225. PubMed ID: 36607525
    [No Abstract]   [Full Text] [Related]  

  • 36. ASO Author Reflections: Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma.
    Kumakura Y; Yokobori T; Sohda M; Shirabe K; Kuwano H
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):741-742. PubMed ID: 30315381
    [No Abstract]   [Full Text] [Related]  

  • 37. ASO Author Reflections: Preservation of the Thoracic Duct is Feasible for Esophageal Squamous Cell Carcinoma Patients Treated with Esophagectomy After Neoadjuvant Chemoradiotherapy.
    Oshikiri T; Numasaki H; Oguma J; Toh Y; Watanabe M; Muto M; Kakeji Y; Doki Y
    Ann Surg Oncol; 2023 May; 30(5):2699-2700. PubMed ID: 36629993
    [No Abstract]   [Full Text] [Related]  

  • 38. ASO Author Reflections: Optimized Cutoff Value of Albumin-Bilirubin Score to Predict Prognosis of Patients with Esophageal Squamous Cell Carcinoma After Radical Resection.
    Shinozuka T; Kanda M; Kodera Y
    Ann Surg Oncol; 2022 Aug; 29(8):4897-4898. PubMed ID: 35362842
    [No Abstract]   [Full Text] [Related]  

  • 39. Additional Esophagectomy Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma: is it a Reasonable Strategy?
    Watanabe M
    Ann Surg Oncol; 2021 Nov; 28(12):6923-6924. PubMed ID: 34309778
    [No Abstract]   [Full Text] [Related]  

  • 40. ASO Author Reflections: Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus.
    Kanda M; Koike M; Kodera Y
    Ann Surg Oncol; 2020 Sep; 27(9):3206-3207. PubMed ID: 32246315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.